DEXCHLORPHENIRAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexchlorpheniramine Maleate, and what generic alternatives are available?
Dexchlorpheniramine Maleate is a drug marketed by Pai Holdings Pharm and Ani Pharms and is included in two NDAs.
The generic ingredient in DEXCHLORPHENIRAMINE MALEATE is dexchlorpheniramine maleate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexchlorpheniramine maleate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXCHLORPHENIRAMINE MALEATE?
- What are the global sales for DEXCHLORPHENIRAMINE MALEATE?
- What is Average Wholesale Price for DEXCHLORPHENIRAMINE MALEATE?
Summary for DEXCHLORPHENIRAMINE MALEATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Clinical Trials: | 5 |
| Patent Applications: | 1,472 |
| DailyMed Link: | DEXCHLORPHENIRAMINE MALEATE at DailyMed |
Recent Clinical Trials for DEXCHLORPHENIRAMINE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| EMS | Phase 3 |
| Mantecorp Industria Quimica e Farmaceutica Ltd. | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for DEXCHLORPHENIRAMINE MALEATE
US Patents and Regulatory Information for DEXCHLORPHENIRAMINE MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pai Holdings Pharm | DEXCHLORPHENIRAMINE MALEATE | dexchlorpheniramine maleate | SYRUP;ORAL | 088251-001 | Mar 23, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | DEXCHLORPHENIRAMINE MALEATE | dexchlorpheniramine maleate | TABLET;ORAL | 088682-001 | Jan 17, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
